Hypersensitivity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2022-05-20
EMA Application withdrawn: Neffy (epinephrine) — Ars Pharmaceuticals Irl Limited
The EMA withdrew the application for Neffy (epinephrine) by Ars Pharmaceuticals Irl Limited.